Plasma d-dimer concentration in patients with systemic sclerosis

Thrombosis Journal

Volumn 4, Issue , 2006, Pages

  Lippi, Giuseppe ^a   Volpe, Alessandro ^a   Caramaschi, Paola ^a   Salvagno, Gian Luca ^a   Montagnana, Martina ^a   Guidi, Gian Cesare ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CREATININE; D DIMER;

ADULT; AGE; ARTICLE; CAPILLAROSCOPY; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FIBRINOLYSIS; FIBROSIS; HEMOSTASIS; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; SEX DIFFERENCE; SKIN DISEASE; SYSTEMIC SCLEROSIS; THROMBOSIS; VASCULAR LESION;

EID: 33746362074     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-4-2     Document Type: Article

References (13)

1. Kahaleh MB: Vascular involvement in systemic sclerosis (SSc). Clin Exp Rheumatol 2004, 223(Suppl 33):S19-23.
2. Maeda M, Kachi H, Mori S: Plasma levels of molecular markers of blood coagulation and fibrinolysis in progressive systemic sclerosis (PSS). J Dermatol Sci 1996, 11:223-7.
3. Ames PR, Lupoli S, Alves J, Atsumi T, Edwards C, Iannaccone L, Khamashta MA, Hughes GR, Brancaccio V: The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. Br J Rheumatol 1997, 36:1045-50.
4. Cerinic MM, Valentini G, Sorano GG, D'Angelo S, Cuomo G, Fenu L, Generini S, Cinotti S, Morfini M, Pignone A, Guiducci S, Del Rosso A, Kalfin R, Das D, Marongiu F: Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum 2003, 32:285-95.
5. Prisco D, Antonucci E, Marcucci R, et al.: D-dimer in the year 2000 current data and new perspectives. Ann Ital Med Int 2000, 15:267-72.
6. American Rheumatism Association Subcommittee for Scleroderma: Criteria of the Therapeutic Criteria Committee, preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980, 23:581-90.
7. Valentini G, Della Rossa A, Bombardieri S, et al.: European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 2001, 60:592-8.
8. Medsger TA Jr, Bombardieri S, Czirjak L, et al.: Assessment of disease severity and prognosis. Clin Exp Rheumatol 2003, 21(3 Suppl 29):S42-6.
9. Arkel YS, Paidas MJ, Ku DH: The use of coagulation activation markers (soluble fibrin polymer, TpP, prothrombin fragment 1.2, thrombin-antithrombin, and D-dimer) in the assessment of hypercoagulability in patients with inherited and acquired prothrombotic disorders. Blood Coagul Fibrinolysis 2002, 13:199-205.
10. Stegnar M, Vene N, Bozic M: Do haemostasis activation markers that predict cardiovascular disease exist? Pathophysiol Haemost Thromb 2003, 33:302-8.
11. Lopez Y, Paloma MJ, Rifon J, et al.: Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states. Thromb Res 1999, 93:71-8.
12. Lippi G, Mengoni A, Manzato F: Plasma D-dimer in the diagnosis of deep vein thrombosis. JAMA 1998, 280:1828-9.
13. Halevy D, Radhakrishnan J, Markowitz G, et al.: Thrombotic microangiopathies. Crit Care Clin 2002, 18:309-20.